Incretin hormone expression in the gut of diabetic mice and rats

Metabolism: Clinical and Experimental

Volumn 46, Issue 3, 1997, Pages 261-267

  Berghöfer, Peter ^b   Peterson, Richard G ^b   Schneider, Kerstin ^b   Fehmann, Hans C ^b   Göke, Burkhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLUCAGON RELEASE; GLUCOSE TOLERANCE TEST; HORMONAL REGULATION; HORMONE RELEASE; INSULIN LIKE ACTIVITY; INTESTINE ABSORPTION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

EID: 0031036270     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90251-1     Document Type: Article

References (50)

1. McIntyre N, Holdsworth CD, Turner DS: New interpretation of oral glucose tolerance. Lancet 2:20-21, 1964
2. Perley MJ, Kipnis DM: Plasma insulin responses to oral and intravenous glucose: Studies in normal and diabetic subjects. J Clin Invest 46:1954-1962, 1967
3. Unger RH, Eisentraut AM: Entero-insular axis. Arch Intern Med 123:261-266, 1969
4. Creutzfeldt W, Ebert R: New developments in the incretin concept today. Diabetologia 28:565-573, 1985
5. Ensinck JW, D'Alessio DA: The entero-insular axis revisited - A novel role for an incretin. N Engl J Med 326:1352-1353, 1992
6. Fehmann HC, Göke R, Göke B: Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390-410, 1995
7. Fehmann HC, Göke B, Göke R, et al: Synergistic stimulatory effect of glucagon-like peptide-I (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. FEBS Lett 252:109-112, 1989
8. Kolligs F, Fehmann HC, Göke R, et al: Reduction of the incretion effect in rats by the glucagon-like peptide I receptor antagonist exendin (9-39) amide. Diabetes 44:16-19, 1995
9. Tseng CC, Jarboe LA, Landau SB, et al: Glucose-dependent insulinotropic peptide: Structure of the precursor and tissue-specific expression in rat. Proc Natl Acad Sci USA 90:1992-1996, 1993
10. Tseng CC, Jarboe LA, Wolfe MM: Regulation of glucose-dependent insulinotropic peptide gene expression by a glucose meal. Am J Physiol 226:G887-G891, 1994
11. Hoyt EC, Lund PK, Winesett DE, et al: Effects of fasting, refeeding, and intraluminal triglyceride on proglucagon expression in jejunum and ileum. Diabetes 45:434-439, 1996
12. Brown JC: Entero-insular axis. Baillieres Clin Endocrinol Metab 2:359-373, 1988
13. Fukase N, Manaka H, Sugiyama K, et al: Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus. Acta Diabetol 32:165-169, 1995
14. Kikutani H, Makino S: The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51:285-322, 1992
15. Tochino Y, Rosenthal AS, Matteo M: The NOC mouse as a model of type I diabetes. Crit Rev Immunol 8:49-85, 1987
16. Peterson RG, Shaw WN, Neel MA, et al: Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News 32:16-19, 1990
17. Sturis J, Pugh WL, Tang J, et al: Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat. Am J Physiol 267:E250-E259, 1994
18. Jia X, Elliott R, Kwok YN, et al: Altered glucose dependence of glucagon-like peptide I (7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas. Diabetes 44:495-500, 1995
19. Friedmann JE, De Venté JE, Peterson RG, et al: Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). Am J Physiol 261:E782-E788, 1991
20. Göke R, Conlon JM: Receptors for glucagon-like peptide-I (7-36) amide on rat insulinoma-derived cells. J Endocrinol 116:357-362, 1988
21. Fujino-Kurihara H, Fujita H, Hakura A, et al: Morphological aspects on pancreatic islets of non-obese diabetic (NOD) mice. Virchows Arch 49:107-120, 1985
22. Linn T, Schneider K, Göke B, et al: GLP-1 improves glucose sensitivity in B-cells of NOD mice. Acta Diabetol 33:19-24, 1996
23. Evers BM, Rajaraman S, Chung SH, et al: Differential expression of the neurotensin gene in the developing rat and human gastrointestinal tract. Am J Physiol 265:G482-G490, 1993
24. Lüttichau HR, Van Solinge WW, Nielsen FC, et al: Developmental expression of the gastrin and cholecystokinin genes in rat colon. Gastroenterology 104:1092-1098, 1993
25. Jin SLC, Hynes MA, Lund PK: Ontogeny of glucagon messenger RNA and encoded precursor in the rat intestine. Regul Pept 25:117-131, 1990
26. Kanayama S, Liddle RA: Regulation of intestinal cholecystokinin and somatostatin mRNA by bombesin in rats. Am J Physiol 261:G71-G77, 1991
27. Eissele R, Göke R, Willemer S, et al: Glucagon-like peptide 1 (7-36) amide-cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22:283-291, 1992
28. Hörsch D, Fink T, Göke B, et al: Distribution and chemical phenotypes of neuroendocrine cells in the human anal canal. Regul Pept 54:527-542, 1995
29. Herrmann C, Göke R, Fehmann HC, et al: Glucagon-like peptide 1 and glucose-dependent insulin-releasing polypeptide secretion in response to nutrients. Digestion 56:117-126, 1995
30. Schirra J, Katschinski M, Weidmann C, et al: Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97:92-103, 1996
31. Petersen RA: Gastric inhibitory polypeptide, in Walsh JH, Dockray GJ (eds): Gut Peptides: Biochemistry and Physiology. New York, NY, Raven, 1994, pp 217-259
32. Creutzfeldt W, Nauck MA: Gut hormones and diabetes mellitus. Diabetes Metab Rev 8:149-177, 1992
33. Morgan LM: The metabolic role of GIP: Physiology and pathology. Biochem Soc Trans 24:585-591, 1996
34. Ross SA, Brown JC, Dupre J: Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus. Diabetes 26:525-529, 1977
35. Ebert R, Creutzfeldt W: Hypo- and hypersecretion of GIP in maturity-onset diabetes. Diabetologia 19:271-272, 1980
36. Nauck MA, Heimesaat MM, Orskov C, et al: Preserved incretin activity of glucagon-like peptide-1 (GLP-1) (7-36) amide but not of synthetic human gastric inhibitory polypeptide (GIP) in patients with type 2 diabetes mellitus. J Clin Invest 30:301-307, 1993
37. Gutniak M, Orskov C, Holst JJ, et al: Antidiabetogenic effect of glucagon-like peptide-1(7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322, 1992
38. Orskov C, Jeppesen J, Madsbad S, et al: Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 87:415-423, 1991
39. Kreymann B, Yiangou Y, Kanse S, et al: Isolation and characterization of GLP-1 7-36 amide from rat intestine: Elevated levels in diabetic rats. FEBS Lett 242:167-170, 1988
40. Brubaker PL, So DCY, Drucker DJ: Tissue-specific differences in the levels of proglucagon-derived peptides in streptozotocin-induced diabetes. Endocrinology 124:3003-3009, 1989
41. O'Brien RM, Granner DK: Gene regulation, in LeRoith D, Taylor SI, Olefsky JM (eds): Diabetes Mellitus. Philadelphia, PA, Lippincott-Raven, 1996, pp 234-242
42. O'Brien RM, Granner DK: The regulation of gene expression by insulin. Physiol Rev 76:1109-1161, 1996
43. Deacon CF, Johnson AH, Hoist JJ: Human colon produces fully processed glucagon-like peptide-I (7-36)amide. FEBS Lett 372:269-272, 1995
44. Fukase N, Takahashi H, Igarashi M, et al: Differences in glucagon-like peptide 1 and GIP responses following sucrose ingestion. Diabetes Res Clin Pract 15:187-195, 1992
45. Göke B, Fuder H, Wieckhorst G, et al: Voglibose (AO-128) is an efficient a-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion 56:493-501, 1995
46. Göke B, Herrmann C, Göke R, et al: Intestinal effects of α-glucosidase inhibitors: Absorption of nutrients and enterohormonal changes. Eur J Clin Invest 24:25-30, 1994 (suppl 3)
47. Leahy JL: Detrimental effects of chronic hyperglycemia on the pancreatic β-cell, in LeRoith D, Taylor SI, Olefsky JM (eds): Diabetes Mellitus. Philadelphia, PA, Lippincott-Raven, 1996, pp 103-113
48. Herrmann-Rinke C, Vöge A, Hess M, et al: Regulation of glucagon-like peptide-1 (GLP-1) secretion from rat ileum by neurotransmitters and peptides. J Endocrinol 147:25-31, 1995
49. Brubaker PL: Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128:3175-3182, 1991
50. Pinto HC, Portella-Gomes GM, Grimelius L, et al: The distribution of endocrine cell types of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology 108:967-974, 1995